Inmediate Effect of the Visualization of Action

June 4, 2018 updated by: Raúl Ferrer-Peña, Universidad Autonoma de Madrid
The observation of actions and motor imagery has demonstrated the activation of certain mechanisms similar to those that occur during active movement, which could induce immediate changes in the amplitudes of movement and sensorimotor variables in observed and imagined movements. The main aim of the study was test the immediate effect of a protocol of observed actions and motor imagery on cervical range of motion and pain intensity in patients with non-specific chronic neck pain (NSCNP). Randomized double-blind clinical trial in patients with DCCI at a primary health care center in the Community of Madrid. A random distribution of study subjects was made into two groups: a) cervical motion videos were presented at full range of motion and b) the videos presented showed a range of motion limited to 40%. In both groups, visualization tasks of actions were alternated with internal kinesthetic motor imagery, in periods of 1min in 2 consecutive series and with a total of 12 minutes of intervention. Cervical range of motion was assessed with a cervical goniometer and pain intensity immediately following the intervention with an Analog Visual Scale.

Study Overview

Study Type

Interventional

Enrollment (Actual)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Madrid, Spain, 28053
        • CS Entrevías

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Nos-Specific Chronic Neck Pain lasting more than 3 months

Exclusion Criteria:

  • Systemic Disease diagnosed (i.e. Lupus, Fibrolyalgia or Rheumatoid Arthritis)
  • Background of fractures or surgery in the cervical region
  • congenital anomalies known
  • infectious processes or diagnosis of active cancer at the time of the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Effective movement group
Observation of a video of neck movement at 100% range of movement, and imagination of the same observed movement, feeling the realization of the movement but not developing it.
Observation of a video of neck movement and imagination of the same observed movement, feeling the realization of the movement but not developing it.
Experimental: Ineffective movement group
Observation of a video of neck movement at 40% range of movement, and imagination of the same observed movement, feeling the realization of the movement but not developing it.
Observation of a video of neck movement and imagination of the same observed movement, feeling the realization of the movement but not developing it.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Cervical Range of Movement
Time Frame: at the beginning and after the intervention, until the end of the study (24 hours)
CROM goniometer
at the beginning and after the intervention, until the end of the study (24 hours)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cervical Pain Disability
Time Frame: at the beginning and end of the intervention, until the end of the study (24 hours)
Neck Disability Index
at the beginning and end of the intervention, until the end of the study (24 hours)
Pain Intensity
Time Frame: at the beginning and end of the intervention, until the end of the study (24 hours)
Visual Ananlogue Scale: 10cm line, were the left limit means "no pain" and the right limit means "worst imaginable pain"
at the beginning and end of the intervention, until the end of the study (24 hours)
Catastrophizism
Time Frame: at the beginning and end of the intervention, until the end of the study (24 hours)
Pain Catastrophizing Scale
at the beginning and end of the intervention, until the end of the study (24 hours)
Health Related Quality of Life
Time Frame: at the beginning and end of the intervention, until the end of the study (24 hours)
EuroQoL-5D-5L
at the beginning and end of the intervention, until the end of the study (24 hours)
Anxiety and Depression
Time Frame: at the beginning and end of the intervention, until the end of the study (24 hours)
Hospital Anxiety and Depression Scale (HADs)
at the beginning and end of the intervention, until the end of the study (24 hours)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2017

Primary Completion (Actual)

April 30, 2018

Study Completion (Actual)

April 30, 2018

Study Registration Dates

First Submitted

May 1, 2018

First Submitted That Met QC Criteria

June 4, 2018

First Posted (Actual)

June 6, 2018

Study Record Updates

Last Update Posted (Actual)

June 6, 2018

Last Update Submitted That Met QC Criteria

June 4, 2018

Last Verified

June 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • OA plus MI in neck pain

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Musculoskeletal Pain

Clinical Trials on observed action and motor imaginery

Subscribe